Anna-sophia Wiekmeijer

Leiden, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Randomized clinical efficacy and safety study of peltopepimut-S plus cemiplimab compared to cemiplimab alone in patients with recurrent/metastatic HPV16-positive head and neck cancer.

Randomized clinical efficacy and safety study of peltopepimut-S plus cemiplimab compared to cemiplimab alone in patients with recurrent/metastatic HPV16-positive head and neck cancer.

Journal: Journal for immunotherapy of cancer

Published: August 22, 2025

Induction of broad multifunctional CD8+ and CD4+ T cells by hepatitis B virus antigen-based synthetic long peptides ex vivo.

Induction of broad multifunctional CD8+ and CD4+ T cells by hepatitis B virus antigen-based synthetic long peptides ex vivo.

Journal: Frontiers in immunology

Published: February 10, 2023

Enhanced HPV16 E6/E7+ tumor eradication via induction of tumor-specific T cells by therapeutic vaccination with virosomes presenting synthetic long peptides.

Enhanced HPV16 E6/E7+ tumor eradication via induction of tumor-specific T cells by therapeutic vaccination with virosomes presenting synthetic long peptides.

Journal: Cancer immunology, immunotherapy : CII

Published: January 27, 2023

Combination immunotherapy with synthetic long peptides and chemotherapy or PD-1 blocker for cancers caused by human papilloma virus type 16.

Combination immunotherapy with synthetic long peptides and chemotherapy or PD-1 blocker for cancers caused by human papilloma virus type 16.

Journal: Seminars in immunopathology

Published: January 24, 2023

A unique immune signature in blood separates therapy-refractory from therapy-responsive acute graft-versus-host disease.

A unique immune signature in blood separates therapy-refractory from therapy-responsive acute graft-versus-host disease.

Journal: Blood

Published: January 28, 2022

The development of T cells from stem cells in mice and humans.

The development of T cells from stem cells in mice and humans.

Journal: Future science OA

Published: December 22, 2016

Overexpression of LMO2 causes aberrant human T-Cell development in vivo by three potentially distinct cellular mechanisms.

Overexpression of LMO2 causes aberrant human T-Cell development in vivo by three potentially distinct cellular mechanisms.

Journal: Experimental hematology

Published: May 26, 2016

The functional relationship between hematopoietic stem cells and developing T lymphocytes.

The functional relationship between hematopoietic stem cells and developing T lymphocytes.

Journal: Annals of the New York Academy of Sciences

Published: January 17, 2016

Development of a diverse human T-cell repertoire despite stringent restriction of hematopoietic clonality in the thymus.

Development of a diverse human T-cell repertoire despite stringent restriction of hematopoietic clonality in the thymus.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: October 21, 2015

Identification of checkpoints in human T-cell development using severe combined immunodeficiency stem cells.

Identification of checkpoints in human T-cell development using severe combined immunodeficiency stem cells.

Journal: The Journal of allergy and clinical immunology

Published: April 14, 2015

The composition and differentiation potential of the duodenal intraepithelial innate lymphocyte compartment is altered in coeliac disease.

The composition and differentiation potential of the duodenal intraepithelial innate lymphocyte compartment is altered in coeliac disease.

Journal: Gut

Published: July 30, 2014

Sustained Engraftment of Cryopreserved Human Bone Marrow CD34(+) Cells in Young Adult NSG Mice.

Sustained Engraftment of Cryopreserved Human Bone Marrow CD34(+) Cells in Young Adult NSG Mice.

Journal: BioResearch open access

Published: June 19, 2014

Showing 1-12 of 12

Last Updated: 09/26/2026